Am

Amyloid

Amyloid: The Journal of Protein Folding Disorders is the official journal of the International Society of Amyloidosis and publishes basic and clinical research on amyloids and systemic and localized amyloidosis. Its scope includes etiology, epidemiology, genetics, pathogenesis, pathology, diagnosis, treatment, and prognosis across clinical specialties affected by amyloid diseases and related disorders. The journal publishes research articles, letters to the Editor, review articles, and article commentaries, with commentaries typically by invitation.

Looking to publish in Amyloid? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Medicine, General & Internal, Medicine, Research & Experimental
Impact Factor 7.4
Quartile Q1
Open Access Type Closed
ISSN 1350-6129
eISSN 1744-2818
Invitation Only No
Cost Range Institutional subscription: USD 3,043.00 online only or USD 4,449.00 print and online; personal subscription pricing available on request.

Submission Instructions

Amyloid accepts the following article types. Click on an article type to view submission instructions.

Research Article

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required. The abstract must be 200 words. The abstract must be structured. The abstract must use the headings Background, Methods, Results, and Conclusions.
Manuscript The manuscript must be no more than 4000 words excluding tables, references, and figure or table captions. The manuscript must be ordered as Title, Authors with affiliations, Abbreviations, Structured abstract, Introduction, Material and methods, Results, Discussion, Acknowledgments, Disclosure statement, and Funding. The manuscript must include 5 to 7 keywords and must acknowledge any use of AI in the paper.
References References must use the T&F standard NLM reference style.
Figures & Tables The manuscript must include no more than 6 figures and tables combined. Figures must be saved separately from the text.
Reformat to Amyloid using Livewrite Premium

Review Article

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required. The abstract must be structured.
Manuscript The manuscript must be ordered as Title, Authors with affiliations, Abbreviations, Structured abstract, Body Text with appropriate headings of the author's choosing, Acknowledgments, Disclosure statement, and Funding. The manuscript must include 5 to 7 keywords and must acknowledge any use of AI in the paper.
References References must use the T&F standard NLM reference style.
Figures & Tables Figures must be saved separately from the text.
Reformat to Amyloid using Livewrite Premium

Letter To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Letters to the Editor must be no more than 1200 words, excluding tables, references, and figure or table captions. Letters to the Editor must be ordered as Title, Authors with affiliations, Text without headings, Acknowledgments, Disclosure statement, Funding, and Supplementary Material, and must begin with the text 'To the Editors.' Letters to the Editor must include 5 to 7 keywords.
References Letters to the Editor must include no more than 10 references. References must use the T&F standard NLM reference style.
Figures & Tables Letters to the Editor must include no more than 1 figure or table. Figures should be saved separately from the text.
Reformat to Amyloid using Livewrite Premium

Article Commentary

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Article Commentary must not exceed 1200 words including tables, references, figure or table captions, and footnotes. Article Commentary text may be divided into subsections with short, informative headings, and the Amyloid article being commented on must be cited in the first sentence. Article Commentary must include 5 to 7 keywords, a disclosure statement, funding details, and acknowledgement of any AI tool use.
References Article Commentary must include no more than 10 references. References must use the T&F standard NLM reference style. The Amyloid article being commented on must appear as the first reference in the reference list.
Figures & Tables Article Commentary must include no more than 1 figure. Figures must be saved separately from the text.
Reformat to Amyloid using Livewrite Premium

Recent Publications

Guidelines for the management of hereditary ATTR amyloidosis 2026

Yoshiki Sekijima, Mitsuharu Ueda, John L. Berk, Laura Obici, Ronald M. Witteles, Violaine Planté-Bordeneuve, Markus Weiler, Marianna Fontana, Márcia Waddington Cruz, Teresa Coelho, Bo-Göran Ericzon, Pablo Garcia-Pavia, João Beirão, Jonas Wixner, Luísa Lobato, Yukio Ando, Giampaolo Merlini, Mathew S. Maurer

10.1080/13506129.2026.2695368
View Publication

Hepatic multimodal phenotyping in AL amyloidosis with cardiac involvement: the D-Amy-LIPHE study

Anna Sessa, Amira Zaroui, Margaux Charles, Stefano Caruso, Julien Calderaro, Jeremy Augustin, Mounira Kharoubi, François Lemonnier, Karim Belhadj, Xue Shaodian, Sébastien Mulé, Emmanuel Itti, Thibaud Damy, Vincent Leroy

10.1080/13506129.2026.2694403
View Publication

Proteostasis is disrupted in human endothelial cells by serum from ATTR patients and is rescued by tafamidis treatment

Despoina D. Gianniou, Dimitrios Delialis, Georgios Georgiopoulos, Dimitrios Bampatsias, Eirini Gkogkou, Foteini Theodorakakou, Panagiota Efstathia Nikolaou, Angeliki Choustoulaki, Alexandros Briasoulis, Ioannis Petropoulos, Eleni-Dimitra Papanagnou, Anna Dimoula, Julie Courraud, Raphael Patras, Angelos Soranidis, Meletios-Athanasios Dimopoulos, Ioannis P. Trougakos, Efstathios Kastritis, Kimon Stamatelopoulos

10.1080/13506129.2026.2689643
View Publication

Fat aspiration for amyloidosis screening of 2830 patients from 2013 to 2020: compelling sensitivity for AL and better sensitivity in females for all major subtypes

Christoph Richard Kimmich, Stefan O. Schönland, Norbert Blank, Tobias Dittrich, Kaya Veelken, Carsten Müller-Tidow, Johan Bijzet, Hans LA Nienhuis, Bouke P. Hazenberg, Ute Hegenbart

10.1080/13506129.2026.2685673
View Publication

Exploring light chain cardiotoxicity in AL amyloidosis: impact on hiPSC-derived cardiomyocyte activity

Serena Calamaio, Anthony Frosio, Dario Melgari, Luca Broggini, Federica Sonzini, Rachele Prevostini, Davide Pignatelli, Luigi Anastasia, Carlo Pappone, Alice Nevone, Giovanni Palladini, Mario Nuvolone, Stefano Ricagno, Ilaria Rivolta

10.1080/13506129.2026.2686787
View Publication

Frequently asked questions

How long does it take to publish?

11 days average from submission to first decision; 29 days average from submission to first post-review decision; 12 days average from acceptance to online publication.

Reformat to Amyloid using Livewrite Premium

What are the publication costs?

Institutional subscription: USD 3,043.00 online only or USD 4,449.00 print and online; personal subscription pricing available on request.

Reformat to Amyloid using Livewrite Premium

Research Topics

Amyloidosis: Diagnosis, Treatment, Outcomes Alzheimer's disease research and treatments Parathyroid Disorders and Treatments Dermatological and Skeletal Disorders Protein Kinase Regulation and GTPase Signaling Cellular transport and secretion Drug Transport and Resistance Mechanisms Trace Elements in Health Multiple Myeloma Research and Treatments Prion Diseases and Protein Misfolding Peptidase Inhibition and Analysis Coagulation, Bradykinin, Polyphosphates, and Angioedema Skin and Cellular Biology Research Pancreatitis Pathology and Treatment Neuroendocrine Tumor Research Advances Medical Imaging and Pathology Studies IgG4-Related and Inflammatory Diseases Protein Structure and Dynamics Eosinophilic Disorders and Syndromes Sarcoidosis and Beryllium Toxicity Research Cardiovascular Function and Risk Factors Ion channel regulation and function Pneumocystis jirovecii pneumonia detection and treatment Intracerebral and Subarachnoid Hemorrhage Research Caveolin-1 and cellular processes

Related Journals

JO
Journal of Urban Health Springer Science+Business Media
BM
BMJ Medicine BMJ
TA
The American Journal of Medicine Elsevier BV
GT
Gene Therapy Springer Nature
BE
BMJ evidence-based medicine BMJ
JO
Journal of Clinical Medicine Multidisciplinary Digital Publishing Institute